Fibre and Appetite Regulation Trial (FART)

NCT ID: NCT00247455

Last Updated: 2011-06-21

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

32 participants

Study Classification

INTERVENTIONAL

Study Start Date

2002-03-31

Study Completion Date

2005-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

High intake of cereal fibre has been shown to be associated with reduced weight gain and improved insulin sensitivity. We hypothesize these effects are due to the short chain fatty acids derived from the bacterial fermentation (breakdown) of fibre in the colon (large intestine). Insulin resistant subjects will be randomized to receive 2 servings of a low-fibre cereal (eg. puffed rice) or 2 servings of a high-fibre cereal (wheat bran cereal) per day for one year. The effects of the diets on body weight, appetite, abdominal fat, blood short chain fatty acids, glucose, insulin, lipids and hormones will be measured

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Obesity Diabetes

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Low fibre breakfast cereal (puffed rice/cornflakes)

Intervention Type DRUG

High fibre cereal (All Bran/Bran Flakes)

Intervention Type DRUG

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Non-diabetic male or non-pregnant females
* aged 18-60
* BMI\<36
* fasting insulin \>40pmol/L (70%ile)

Exclusion Criteria

* intention to lose \>5kg in weight
* presence of diabetes (fasting glucose \>6.9mmol/L)
* use of diuretics, beta-blockers or weight reducing drugs
* use of antibiotics in last 3 months and use of antibiotics more than once annually for the last 2 years
* significant gastrointestinal, liver or kidney disease
* use of lipid-lowering drug
* major medical or surgical event in last 6 mo.
* fibre intake \>30g/d
* inability to eat low or high fibre breakfast cereals
* unwilling or unable to give consent or comply with protocol
Minimum Eligible Age

18 Years

Maximum Eligible Age

60 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Canadian Diabetes Association

OTHER

Sponsor Role collaborator

Canadian Institutes of Health Research (CIHR)

OTHER_GOV

Sponsor Role collaborator

University of Toronto

OTHER

Sponsor Role lead

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Thomas MS Wolever, BM, BCh, PhD, DM

Role: PRINCIPAL_INVESTIGATOR

University of Toronto

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

St. Michael's Hospital

Toronto, Ontario, Canada

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Canada

References

Explore related publications, articles, or registry entries linked to this study.

Freeland KR, Wilson C, Wolever TM. Adaptation of colonic fermentation and glucagon-like peptide-1 secretion with increased wheat fibre intake for 1 year in hyperinsulinaemic human subjects. Br J Nutr. 2010 Jan;103(1):82-90. doi: 10.1017/S0007114509991462. Epub 2009 Aug 7.

Reference Type RESULT
PMID: 19664300 (View on PubMed)

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

Can Diabetes Assoc Grant 1323

Identifier Type: -

Identifier Source: secondary_id

CIHR Grant OOP-64648

Identifier Type: -

Identifier Source: secondary_id

CDA1323

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

PERFECT Project - Part 1 - Study 2
NCT02366572 COMPLETED NA
Focus on Fibre Study
NCT05449665 TERMINATED NA